Vanguard Personalized Indexing Management, LLC Amicus Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 24,699 shares of FOLD stock, worth $219,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,699
Previous 17,887
38.08%
Holding current value
$219,821
Previous $102,000
90.2%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding FOLD
# of Institutions
304Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$262 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$259 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$217 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$160 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$130 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.5B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...